The score is not available for this stock. This could be because (a) the market cap of the... Read More
Value score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
Price Momentum score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
QVM score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
GVBL Key Metrics
GVBL Share Price
Stock Analysis
Snapshot
Shareholding Pattern
Bulk, Block & Insider Trades
Corporate Actions
Company Profile
GVBL Share Price
GVBL
1 Week returns: -
1 Month returns: -
1 Year returns: -
3 Years CAGR: -
5 Years CAGR: -
Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
GVBL Stock Analysis
Views
Red Flags
Positive
Strong revenue growth and above median growth of industry
Low Debt to Equity, not much change from last year
Company is net cash
Negative
Expensive and at same valuation levels as industry median P/E
Low and declining ROE
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
High operating margin but declining trend
Stock in GSM list
The stock has been places in Graded Surveillance Measure (GSM) list (GSM - 0).
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0142134.
Snapshot
See detailed analysis
GVBL Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
GVBL Bulk, Block & Insider Trades
GVBL Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
No capital change events found
Company Profile
Genomic Valley Biotech Limited is an India-based company, which is engaged in the business of consultancy, and trading in agricultural and horticultural products. The Company is providing consultancy on high-tech cultivation through environment-controlled poly houses, NFT & DFT and others, and organ... Read More
Key personnel
Mr. Yogesh Kumar AgrawalD
Executive Chairman of the Board, Managing Director, Chief Financial Officer
Mrs. Aditya Aditya
Company Secretary, Compliance Officer
Mrs. Parul AgrawalD
Non-Executive Non Independent Director
Mrs. Jyoti BansalD
Additional Non-Executive Independent Director
Mr. Yogainder Kumar GuptaD
Non-Executive Independent Director
Mr. Praveen Kumar MishraD
Additional Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Address
Frequently asked questions
What is the current share price of Genomic Valley Biotech Ltd.?
The current share price of Genomic Valley Biotech Ltd. is ₹ 25.69 as of 09 Jan 2026.
What is the PE ratio of Genomic Valley Biotech Ltd.?
The Price-to-Earnings (PE) ratio of Genomic Valley Biotech Ltd. is 78.61 as of the latest financial data.
What is the ROE and ROCE of Genomic Valley Biotech Ltd.?
Genomic Valley Biotech Ltd. has a Return on Equity (ROE) of 2.58% and a Return on Capital Employed (ROCE) of 4.77% as per the latest financial reports.
What is the market cap of Genomic Valley Biotech Ltd.?
The market capitalization of Genomic Valley Biotech Ltd. stands at ₹ 7.85 Cr.
What is the dividend yield of Genomic Valley Biotech Ltd.?
The dividend yield of Genomic Valley Biotech Ltd. is 0.00% based on the current market price.
What is the RSI of Genomic Valley Biotech Ltd.?
The Relative Strength Index (RSI) of Genomic Valley Biotech Ltd. is 50.78.
What is the FII and DII holding in Genomic Valley Biotech Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Genomic Valley Biotech Ltd. shares.
What sector does Genomic Valley Biotech Ltd. belong to?
Genomic Valley Biotech Ltd. operates in the Healthcare sector.
What is the beta of Genomic Valley Biotech Ltd. stock?
The beta of Genomic Valley Biotech Ltd. stock is 0.53, indicating its volatility relative to the broader market.
